Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast (CC10004) in severe plaque psoriasis
NCT00604682Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Jan 2005; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00604682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604682.